Australian Clinical Labs
ACL.AX
#7692
Rank
A$0.53 B
Marketcap
A$2.78
Share price
-0.36%
Change (1 day)
-23.06%
Change (1 year)

EPS for Australian Clinical Labs (ACL.AX)

EPS in 2024: A$0.11

According to Australian Clinical Labs's latest financial reports the company's current EPS (TTM) is A$0.11. In 2024 the company made an earnings per share (EPS) of A$0.11 a decrease over its 2023 EPS that were of A$0.17.

EPS history for Australian Clinical Labs from 2021 to 2024

Annual EPS

Year EPS Change
2024A$0.11-32.69%
2023A$0.17-80.47%
2022A$0.87105.25%
2021A$0.42